These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 29171987)
21. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer. Ge F; Wang C; Wang W; Liu W; Wu B Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284 [TBL] [Abstract][Full Text] [Related]
22. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. Su Z; Zhao J; Rong Z; Geng W; Wang Z Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660 [TBL] [Abstract][Full Text] [Related]
23. miR-488 acts as a tumor suppressor gene in gastric cancer. Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864 [TBL] [Abstract][Full Text] [Related]
24. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
25. Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2. Liu LY; Wang W; Zhao LY; Guo B; Yang J; Zhao XG; Hou N; Ni L; Wang AY; Song TS; Huang C; Xu JR Int J Oncol; 2014 Sep; 45(3):1257-65. PubMed ID: 24969300 [TBL] [Abstract][Full Text] [Related]
26. Expression of miR-126 and Crk in endometriosis: miR-126 may affect the progression of endometriosis by regulating Crk expression. Liu S; Gao S; Wang XY; Wang DB Arch Gynecol Obstet; 2012 Apr; 285(4):1065-72. PubMed ID: 22012249 [TBL] [Abstract][Full Text] [Related]
27. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance. Liu K; Li G; Fan C; Diao Y; Wu B; Li J J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1. Hu L; Wu H; Wan X; Liu L; He Y; Zhu L; Liu S; Yao H; Zhu Z Biochem Biophys Res Commun; 2018 Apr; 499(1):52-58. PubMed ID: 29550487 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients. Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131 [TBL] [Abstract][Full Text] [Related]
30. Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer. Jing LL; Mo XM Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1516-20. PubMed ID: 27160123 [TBL] [Abstract][Full Text] [Related]
31. [Expression of microRNA-183 in stage II ( gastric cancer and its association with Ezrin protein]. Zheng WW; Huang CM; Xie JW; Zheng CH; Li P; Wang JB; Lin JX Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):723-6. PubMed ID: 22851079 [TBL] [Abstract][Full Text] [Related]
32. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer. Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of miR-141 downregulation in gastric cancer. Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225 [TBL] [Abstract][Full Text] [Related]
34. Dysregulation of miR-195-5p/-218-5p/BIRC5 axis predicts a poor prognosis in patients with gastric cancer. Zou J; Liao X; Zhang J; Wang L J Biol Regul Homeost Agents; 2019; 33(5):1377-1385. PubMed ID: 31663299 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes. Wen X; Wu JQ; Peng W; Feng JF; Tang JH Oncol Rep; 2015 Jul; 34(1):203-10. PubMed ID: 25998046 [TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338 [TBL] [Abstract][Full Text] [Related]
37. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517 [TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic value of miR-92a in patients with gastric cancer. Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436 [TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. Gong Y; Ren J; Liu K; Tang LM World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292 [TBL] [Abstract][Full Text] [Related]
40. Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer. LArki P; Ahadi A; Zare A; Tarighi S; Zaheri M; Souri M; Zali MR; Ghaedi H; Omrani MD Iran Biomed J; 2018 Nov; 22(6):367-73. PubMed ID: 29859516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]